Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study

Gynecologic Oncology

Volumn 100, Issue 3, 2006, Pages 537-543

  Long III, Harry J ^a   Monk, Bradley J ^b   Huang, Helen Q ^c   Grendys Jr , Edward C ^d   McMeekin, D Scott ^e   Sorosky, Joel ^f   Miller, David S ^g   Eaton, Lynne A ^h   Fiorica, James V ⁱ  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^g UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^h THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

ⁱ H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Cervix cancer; Combination chemotherapy; Phase III

Indexed keywords

CISPLATIN; DOXORUBICIN; METHOTREXATE; TOPOTECAN; VINBLASTINE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER GROWTH; CANCER SURVIVAL; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; INFECTION; LEUKOPENIA; MAJOR CLINICAL STUDY; NAUSEA; NEUTROPENIA; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; METHOTREXATE; QUALITY OF LIFE; TOPOTECAN; UTERINE CERVICAL NEOPLASMS; VINBLASTINE;

EID: 32644468357     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2005.09.023     Document Type: Article

References (15)

1. T. Thigpen, H. Shingleton, H. Homesley, L. LaGasse, and J. Blessing Cis-dichlorodiammineplatinum (II) in the treatment of gynecologic malignancies: Phase II trials by the Gynecologic Oncology Group Cancer Treat. Rep. 63 1979 1549 1555
2. G.A. Omura, J.A. Blessing, and L. Vaccarella Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study J. Clin. Oncol. 15 1997 165 171
3. D.H. Moore, J.A. Blessing, and R.P. McQuellon A randomized phase III study of cisplatin versus cisplatin plus paclitaxel in Stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study J. Clin. Oncol. 22 15 2004 3113 3119
4. J. Fiorica, R. Holloway, and B. Ndubisi Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix Gynecol. Oncol. 85 2002 89 94
5. H.J. Long, W.G. Cross, and H.S. Wieand Phase II trial of methotrexate, vinblastine, doxorubicin and cisplatin in advanced/recurrent cancer of the uterine cervix and vagina. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic Gynecol. Oncol. 57 1995 235 239
6. C.A. Papadimitriou, M.A. Dimopoulos, and N. Giannakoulis A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix Cancer 79 1997 2391 2399
7. H.J. Long III, B.N. Bundy, and E.C. Grendys Jr. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group study J. Clin. Oncol. 23 21 2005 4626 4633
8. B.J. Monk, H.Q. Huang, D. Cella, and H.J. Long III Quality of life outcomes from a randomized phase III trial of cisplatin with or without topotecan in advanced carcinoma of the cervix: a Gynecologic Oncology Group study J. Clin. Oncol. 23 21 2005 4617 4625
9. D.H. Moore, J.A. Blessing, and R. McQuellon Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent or persistent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study J. Clin. Oncol. 22 15 2004 3113 3119
10. D.F. Cella, D.S. Tulsky, and G. Gray The functional assessment of cancer therapy scale: development and validation of the general measure J. Clin. Oncol. 11 1993 570 579
11. Functional Assessment of Chronic Illness Therapy. http://www.facit.org.
12. E.A. Calhoun, E.E. Welshman, and C.H. Chang Psychometric evaluation of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy Int. J. Gynecol. Cancer 13 6 2003 741 748
13. C.S. Cleeland, and K.M. Ryan Pain assessment: global use of the Brief Pain Inventory Ann. Acad. Med. 23 2 1994 129 138
14. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J. Am. Stat. Assoc. 53 1958 457 481
15. D.R. Cox Regression model and life tables (with discussion) J. R. Stat. Soc. 34B 1972 187